4//SEC Filing
HAMILTON WARD W 4
Accession 0001181431-12-026434
CIK 0000887568other
Filed
Apr 29, 8:00 PM ET
Accepted
Apr 30, 6:09 PM ET
Size
25.2 KB
Accession
0001181431-12-026434
Insider Transaction Report
Form 4
HAMILTON WARD W
Senior VP, Marketing
Transactions
- Tax Payment
Common Stock
2012-04-26−653→ 0 total - Exercise/Conversion
Common Stock
2012-04-26$20.23/sh+3,750$75,863→ 8,125 total - Disposition to Issuer
Common Stock
2012-04-26$93.00/sh−16,125$1,499,625→ 0 total - Exercise/Conversion
Stock Option
2012-04-26−1,875→ 0 totalExercise: $23.05From: 2008-11-14Exp: 2017-11-14→ Common Stock (1,875 underlying) - Exercise/Conversion
Stock Option
2012-04-26−3,000→ 0 totalExercise: $37.67From: 2012-11-15Exp: 2021-11-15→ Common Stock (3,000 underlying) - Exercise/Conversion
Common Stock
2012-04-26$37.67/sh+3,000$113,010→ 16,125 total - Exercise/Conversion
Common Stock
2012-04-26$30.27/sh+5,000$151,350→ 13,125 total - Exercise/Conversion
Stock Option
2012-04-26−2,500→ 0 totalExercise: $22.05From: 2009-11-11Exp: 2018-11-11→ Common Stock (2,500 underlying) - Disposition to Issuer
Common Stock
2012-04-26$93.00/sh−1,347$125,271→ 0 total - Exercise/Conversion
Stock Option
2012-04-26−5,000→ 0 totalExercise: $30.27From: 2011-11-16Exp: 2020-11-16→ Common Stock (5,000 underlying) - Exercise/Conversion
Common Stock
2012-04-26$23.05/sh+1,875$43,219→ 1,875 total - Exercise/Conversion
Common Stock
2012-04-26$22.05/sh+2,500$55,125→ 4,375 total - Exercise/Conversion
Stock Option
2012-04-26−3,750→ 0 totalExercise: $20.23From: 2010-11-10Exp: 2019-11-10→ Common Stock (3,750 underlying)
Footnotes (3)
- [F1]These restricted stock awards vested in full and were cancelled immediately prior to the effective time of the merger (the "Merger") pursuant to that certain Agreement and Plan of Merger, dated March 12, 2012, by and among ZOLL Medical Corporation, Asahi Kasei Corporation, Asahi Kasei Holdings US, Inc. and Asclepius Subsidiary Corporation (the "Merger Agreement") in exchange for an aggregate cash payment equal to the number of shares of ZOLL Medical Corporation's common stock underlying such restricted stock awards multiplied by the per share purchase price of $93.00.
- [F2]Disposed of at the effective time of the Merger pursuant to the terms of the Merger Agreement.
- [F3]Represents options under ZOLL Medical Corporation's Amended and Restated 2001 Stock Incentive Plan that were either fully exercisable or accelerated in full and exercised pursuant to the terms of the Merger Agreement.
Documents
Issuer
ZOLL MEDICAL CORP
CIK 0000887568
Entity typeother
Related Parties
1- filerCIK 0001237796
Filing Metadata
- Form type
- 4
- Filed
- Apr 29, 8:00 PM ET
- Accepted
- Apr 30, 6:09 PM ET
- Size
- 25.2 KB